Coronary Artery Bypass Graft Surgery (CABG)

Coronary artery bypass graft surgery is one of the most performed open-heart procedures in the United States, used to restore blood flow past critically narrowed or blocked coronary arteries. This page covers the procedural definition, operative mechanism, clinical scenarios that drive its use, and the decision boundaries that distinguish it from catheter-based alternatives. Understanding CABG in technical terms is essential for patients navigating advanced coronary artery disease and for clinicians applying guideline-based care under established cardiovascular standards.

Definition and scope

CABG is a surgical procedure in which a conduit vessel — harvested from elsewhere in the patient's body — is grafted to bypass a segment of obstructed coronary artery, creating a new route for oxygenated blood to reach the myocardium. The procedure addresses the mechanical consequence of coronary artery disease: plaque accumulation that reduces luminal diameter to the point where downstream myocardial tissue is ischemic or at imminent risk of infarction.

The American Heart Association (AHA) and the American College of Cardiology (ACC) publish joint guidelines on myocardial revascularization that establish the evidence base for CABG indications. The most recent major iteration — the 2021 ACC/AHA Guideline for Coronary Artery Revascularization — classifies recommendations using a Class I through III framework and assigns evidence levels (A, B, C), providing the primary regulatory-adjacent standard against which surgical decision-making is measured (ACC/AHA 2021 Guideline for Coronary Artery Revascularization).

The Centers for Medicare & Medicaid Services (CMS) classifies CABG under Diagnosis-Related Group (DRG) codes 231–236, which determines hospital reimbursement under the Inpatient Prospective Payment System (CMS DRG definitions). This coding structure influences how institutions document procedure complexity and comorbidity burden.

How it works

CABG is performed in four broad phases:

Conduit harvest — The surgeon identifies and harvests a bypass conduit. The left internal mammary artery (LIMA), connected to the left subclavian artery, is the preferred conduit for bypassing the left anterior descending (LAD) artery because of its demonstrated long-term patency rates, exceeding 90% at 10 years according to data reviewed in ACC/AHA guidelines. The great saphenous vein, harvested from the leg, and the radial artery are secondary conduits.
Cardiopulmonary bypass (on-pump) — In conventional CABG, the patient is connected to a heart-lung machine that oxygenates blood and maintains circulation while the heart is arrested using a cardioplegic solution. This allows anastomosis on a motionless field.
Anastomosis — The conduit is sutured proximal to the obstruction (at the aorta or a branch vessel) and distal to it, creating a bypass channel. A single operation may construct 2 to 5 grafts depending on the number of diseased vessels.
Weaning and closure — The heart is restarted, the patient is separated from bypass, hemostasis is achieved, and the sternum is closed with sternal wires.

Off-pump CABG (OPCAB) performs the anastomoses on a beating heart using mechanical stabilizers, avoiding cardiopulmonary bypass entirely. This variant is associated with reduced embolic risk in certain patient populations but requires equivalent surgical expertise and is not universally superior in outcomes; the ROOBY trial, published by the Veterans Affairs Cooperative Studies Program, found no significant mortality advantage for OPCAB versus on-pump CABG at 1 year.

The full procedural and outcomes landscape for CABG intersects with the broader regulatory context for cardiology, which governs quality reporting, credentialing, and institutional volume thresholds tied to CMS and The Joint Commission standards.

Common scenarios

CABG is applied across a defined set of clinical presentations:

Left main coronary artery stenosis ≥50%: The ACC/AHA guidelines assign a Class I recommendation for CABG in patients with significant left main disease, reflecting the large myocardial territory at risk.
Three-vessel coronary artery disease with reduced left ventricular ejection fraction (LVEF ≤35%): Surgical revascularization shows a survival benefit over medical therapy alone, supported by the STICH trial (Surgical Treatment for Ischemic Heart Failure), conducted under National Institutes of Health funding.
Two-vessel disease involving the proximal LAD: Given the LAD's role in perfusing the anterior wall, proximal obstruction carries Class I CABG consideration.
Failed percutaneous coronary intervention (PCI): Emergency CABG addresses acute complications such as coronary dissection or inability to achieve adequate stent deployment.
Diabetes mellitus with multivessel disease: The FREEDOM trial demonstrated superior 5-year outcomes with CABG compared to angioplasty and stenting in diabetic patients with multivessel coronary disease, with a 47% relative reduction in the composite of death, myocardial infarction, or stroke favoring CABG (FREEDOM trial, NEJM 2012).

Decision boundaries

The central decision axis in revascularization is CABG versus PCI, adjudicated using the SYNTAX score — an angiographic tool that quantifies lesion complexity. A SYNTAX score above 33 generally favors CABG, while scores below 22 may favor PCI, with intermediate scores requiring Heart Team deliberation as specified in ACC/AHA guidance.

A multidisciplinary Heart Team, typically comprising interventional cardiologists, cardiac surgeons, and often imaging specialists, is the recommended deliberative structure for non-emergent revascularization decisions. The cardiology vs. cardiac surgery boundary is a defining feature of these deliberations, as procedural ownership affects both patient routing and institutional credentialing.

Risk stratification uses the Society of Thoracic Surgeons (STS) Predicted Risk of Mortality (PROM) score, calculated from patient-level variables including age, ejection fraction, renal function, and prior cardiac surgery (STS Risk Calculator). An STS PROM above 8% typically marks high operative risk and triggers evaluation of transcatheter alternatives such as transcatheter aortic valve replacement for co-existing valvular pathology, or hybrid revascularization strategies.

Patients with prior CABG who develop graft failure face a separate decision matrix. Redo CABG carries incrementally higher operative risk than index surgery — STS data place redo operative mortality at roughly 2 to 3 times that of primary CABG — making PCI to native vessels or patent grafts a common alternative when anatomy permits.

The full scope of cardiovascular care, from initial diagnosis through post-surgical management, is indexed at cardiologyauthority.com, where procedural topics are placed within their clinical and regulatory contexts.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)